Board to consider and approve Epigral’s standalone and consolidated Q3 and nine-month results for the quarter ended 31 December 2025, with the Limited Review Report.
AI Assistant
Epigral Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.